Latest / CareTalk: Healthcare. Unfiltered.
Blue Shield of CA's Bold Move to Bypass PBMs
Send us Fan Mail
It’s no secret that medical drug prices have been out of control for most Americans.
However, one hospital group has a novel idea to control drug spending.
Blue Shield of California is bypassing PBMs by negotiating directly with the manufacturer of a biosimilar for Humira.
Is this a one-off experiment or the start of a bigger trend that can drive industry-wide impact?
In this episode of CareTalk, David E. Williams and John Driscoll discuss these price negotiation tactics and what they see as the long-term results of Blue Shield of California’s attempt to lower pharmaceutical…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.